Picture of Icure Pharmaceutical logo

175250 Icure Pharmaceutical Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapNeutral

Annual balance sheet for Icure Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

R2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:Interim ReportAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments36,17513,71824,41753,7868,558
Net Total Accounts Receivable
Net Total Receivables15,07517,35017,14416,2218,986
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets68,89743,72658,79680,70531,812
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment97,306107,813101,31296,94393,526
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets215,798195,149215,448224,121166,137
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities36,78734,11054,818109,98195,439
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities118,26782,995119,693134,450107,900
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity97,531112,15495,75589,67158,238
Total Liabilities & Shareholders' Equity215,798195,149215,448224,121166,137
Total Common Shares Outstanding